Skip to main content
Asarina Pharma AB logo

Asarina Pharma AB — Investor Relations & Filings

Ticker · ASAP ISIN · SE0011641794 LEI · 549300PP1GKOHKYQ6K97 ST Professional, scientific and technical activities
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing ST ASAP

About Asarina Pharma AB

https://asarinapharma.com/

Asarina Pharma was a biotechnology company focused on developing Sepranolone, a therapy for disorders related to the neurosteroid allopregnanolone. The company's research targeted conditions including premenstrual dysphoric disorder (PMDD), Tourette syndrome, and other stress- and compulsion-driven disorders. Following the sale of its primary asset, Sepranolone, to Relmada Therapeutics, the company has entered into liquidation.

Recent filings

No filings indexed yet

We are still gathering filings for Asarina Pharma AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.